REG - Ergomed plc - COO, Lewis Cameron, joins Ergomed

ErgomedAnnouncement

20/01/2020 07:05

RNS Number : 2392A
Ergomed plc
20 January 2020
 


 PRESS RELEASE
 
Chief Operating Officer, Lewis Cameron, joins Ergomed
Guildford, UK - 20 January 2020: On 2 December 2019, Ergomed plc (LSE: ERGO) ("Ergomed" or the "Company"), a company focused on providing specialised services to the pharmaceutical industry, announced the appointment of Lewis Cameron as Chief Operating Officer (COO) and to the Board. Ergomed confirms that, as stated in that announcement, Lewis has today commenced his employment as COO and his appointment to the Board has been effected.     
Ergomed confirms that there have been no changes to the disclosures made in the announcement dated 2 December 2019 (RNS number 2883V) regarding Rule 17 of paragraph (g) of Schedule Two of the AIM Rules for Companies in respect of Lewis Cameron's appointment.
 
ENDS
 
Enquiries:
 



Ergomed plc


 Tel: +44 (0) 1483 402 975




Miroslav Reljanović (Executive Chairman)








Richard Barfield (Chief Financial Officer)


















Numis Securities Limited


Tel: +44 (0) 20 7260 1000




Freddie Barnfield / Huw Jeremy (Nominated Adviser)








James Black (Broker)


















Consilium Strategic Communications - for UK enquiries


Tel: +44 (0) 20 3709 5700




Chris Gardner / Sue Stuart


ergomed@consilium-comms.com




Matthew Neal / Olivia Manser

















 
 
About Ergomed plc
Ergomed provides specialist services to the pharmaceutical industry spanning all phases of clinical trials, post-approval pharmacovigilance and medical information. Ergomed's fast-growing, profitable services business includes a full range of high-quality contract research and clinical trial management (CRO) services under the Ergomed brand together with an industry-leading suite of specialist pharmacovigilance (PV) solutions, integrated under the PrimeVigilance brand, and an internationally recognized specialist expertise in orphan drug development, under the PSR brand. For further information, visit: http://ergomedplc.com.
 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAKKLFFBFLLBBV